Malignant News and Research

RSS

Immune System Changes Occur Early In Development Of Multiple Myeloma

Immune System Changes Occur Early In Development Of Multiple Myeloma

Before multiple myeloma becomes a malignant disease, the collection of immune system cells and signal carriers amid the tumor cells undergo dramatic shifts.

29 Apr 2020

Pancreatic tumors hijack basic cell mechanism for immune evasion

Pancreatic tumors hijack basic cell mechanism for immune evasion

Pancreatic cancer cells use a normal waste removal process to hide tags on their surfaces that would otherwise let the immune system destroy them, a new study finds. Published online April 22 in Nature, the study results help to answer a longstanding question: why are pancreatic cancers so resistant to immunotherapies, which use the body's own immune defenses to fight cancer?

24 Apr 2020

A Cellular Mechanism Protecting Against Cancer

A Cellular Mechanism Protecting Against Cancer

Researchers at the University of Bayreuth have discovered a natural protective mechanism that leads to the programmed death of potentially diseased cells.

24 Apr 2020

Large mutations may explain diverse outcomes from autism genes

Large mutations may explain diverse outcomes from autism genes

Scientists have recently discovered large mutations that may explain diverse outcomes from autism genes and this story investigates further.

25 Mar 2020

Combining AIMS with machine learning to speed up breast cancer diagnosis

Combining AIMS with machine learning to speed up breast cancer diagnosis

Researchers have conducted a study showing that combining an AIMS approach with machine learning could speed up the diagnosis of breast cancer.

15 Feb 2020

Applying integrated lipidomics and proteomics in multiple myeloma reveals potential disease pathways

Applying integrated lipidomics and proteomics in multiple myeloma reveals potential disease pathways

A team of Australian researchers has confirmed the feasibility and potential of applying integrated lipidomics and proteomics to malignant plasma cells from myeloma patients.

13 Feb 2020

Previous
1
...
7
8
9
10

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.